COMMUNIQUÉS West-GlobeNewswire

Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors
24/05/2018
- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
24/05/2018
THE WOODLANDS, Texas, May 24, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
Natus to Present at Jefferies 2018 Healthcare Conference
24/05/2018
PLEASANTON, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jim Hawkins, President and Chief Executive Officer will present at the Jefferies 2018 Healthcare [...]
Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress
24/05/2018
CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) today announced that on Friday, May 25, 2018, at the European Renal Association – European Dialysis and [...]
Protalix Announces Exchange and Discharge of Remaining 2018 Notes
24/05/2018
CARMIEL, Israel, May 24, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (the “Company”) (NYSE American:PLX) (TASE: PLX ) announced today that $3.42 million of the aggregate principal amount of the Company’s [...]
Recro Pharma Receives Complete Response Letter from the FDA
24/05/2018
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Penn., May 24, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for [...]
Hydropothecary launches a new brand for recreational cannabis: Introducing HEXO
24/05/2018
The company announces application to graduate to the Toronto Stock Exchange TORONTO, May 24, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSXV:THCX) (“Hydropothecary” or “The Company”) today introduced HEXO [...]
Hydropothecary lance une nouvelle marque de cannabis récréatif : HEXO
24/05/2018
L’entreprise annonce une demande d’inscription pour passer à la Bourse de Toronto TORONTO, 24 mai 2018 (GLOBE NEWSWIRE) -- Aujourd’hui, la Société Hydropothecary (TSXV:THCX) (« Hydropothecary » ou la « Société ») a [...]
CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine
24/05/2018
OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent [...]
BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
24/05/2018
RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), today announced that [...]
PRA Named International Clinical Research Company of the Year
24/05/2018
RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the [...]
Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products
24/05/2018
Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products Lugano, Switzerland, May 24, 2018 – Helsinn, a Swiss pharmaceutical group focused on [...]
Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®
24/05/2018
Vienna, Austria, 24 May 2018 - People treated with Saxenda ® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. [...]
Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease
24/05/2018
Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run [...]
Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease
24/05/2018
Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run [...]
Immunicum AB: Invitation to Investor Event
24/05/2018
Press Release 24 May 2018 Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa [...]
Shire plc : Rule 2.9 Announcement
24/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 May 2018 Shire [...]
Saniona publishes its interim report for the first quarter 2018
24/05/2018
PRESS RELEASE May 24, 2018 Financial highlights Q1 2018 (Q1 2017) Net revenues were SEK 4.3 M (7.5 M) EBIT was SEK -15.7 M (-7.6 M) Net profit/loss was SEK -13.5 M (-6.4 M) Earnings per share were SEK -0.62 (-0.31) [...]
Bavarian Nordic Announces Interim Results for the First Three Months of 2018
24/05/2018
COPENHAGEN, Denmark, May 24, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first three months of 2018. First quarter highlights and [...]

Pages